Eris Lifesciences has signed a definitive agreement with Biocon Biologics to acquire its Branded Formulations’ India (BFI) business units of nephrology and dermatology.
Eris Lifesciences has signed a definitive agreement with Biocon Biologics to acquire its Branded Formulations’ India (BFI) business units of nephrology and dermatology. Eris Lifesciences has signed a definitive agreement with Biocon Biologics to acquire its Branded Formulations’ India (BFI) business units of nephrology and dermatology. Moneycontrol Latest News Read More
